NCODA

What NCODA does

NCODA (National Community Oncology Dispensing Association) is a 501(c)(3) nonprofit medical association founded in 2015 and headquartered in Cazenovia, NY. The organization serves oncology healthcare professionals — primarily pharmacists, physicians, pharmacy technicians, advanced practice providers, oncology nurses, and practice administrators — who work within medically integrated oncology practices. NCODA's central thesis is that embedding pharmacists within the oncology care team improves treatment adherence, reduces hospitalizations related to treatment toxicity, and lowers total cost of care.

The organization operates a web-based member platform (my.ncoda.org / NCODA CONNECT, powered by Higher Logic) that hosts a resource library of more than 1,000 clinical and patient-facing resources. Core proprietary assets include the Positive Quality Interventions (PQI) clinical intervention framework, the Cost Avoidance and Waste Tracker (CAWT), the Oncology Optimized Limited Distribution (OOLD) model, the Medically Integrated Pharmacy Accreditation program, and an Immunotherapy Hub. NCODA also produces a podcast, continuing education content (ACPE- and PACE-accredited), patient education sheets and treatment calendars, a legislation tracker, and clinical white papers. Distribution is anchored by 100+ educational events per year, including the International Spring Forum, International Fall Summit, Global Oncology & Haematology Congress, and Oncology Institute.

NCODA's revenue model is a hybrid typical of professional associations: (1) recurring annual membership dues from individual oncology professionals and practice members, (2) tiered corporate partnerships from pharmaceutical and healthcare industry sponsors (Emerging through Diamond levels), (3) event registration fees (waived or reduced for members), and (4) continuing education activity fees. The organization monetizes community reach and clinical content authority rather than selling a discrete product, with corporate sponsorship functioning as the most discretionary revenue stream tied to pharma marketing cycles.

Name

NCODA

Legal name

National Community Oncology Dispensing Association

Website

https://ncoda.org

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

NCODA is a 501(c)(3) nonprofit association founded in 2015 that serves 16,000+ oncology professionals across 70+ countries through clinical resources, accreditation, continuing education, and international events supporting medically integrated oncology pharmacy practice.

Ownership category

akta.pro rank

Product category

Oncology Professional Association Services

NAICS

Business Associations (813910)

SIC

Services-Membership Organizations (8600), Services-Educational Services (8200)

akta.pro primary industry

Continuing Education (CE/CPD) & Provider Accreditation Bodies (EDADACAF)

akta.pro secondary industries

Healthcare & Clinical Professional Certifications (EDAAANAI), Chronic Disease & NCD Program Evaluation (e.g., diabetes/CVD/cancer) (HLAJANAG)

Keywords

• Oncology professional association
• Medically integrated pharmacy
• Oncology clinical resources
• Pharmacy continuing education
• Oncology practice accreditation

Headquarters

HQ city

Cazenovia

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Professional Membership Dues: NCODA generates revenue through annual membership fees from oncology healthcare professionals including pharmacists, physicians, nurses, pharmacy technicians, and practice administrators. Membership provides access to resources, education, and networking opportunities.
2. Industry Sponsorships and Corporate Partnerships: Pharmaceutical companies and healthcare industry partners sponsor NCODA events, educational content, and initiatives. The become-a-partner page indicates corporate partnership opportunities from Emerging to Diamond levels.
3. Event Registration Fees: NCODA charges registration fees for its international conferences and forums. Non-member healthcare practitioners and those outside oncology practice settings pay fees while members receive complimentary or reduced-cost access.
4. Continuing Education Programs: NCODA is accredited by ACPE for pharmacy continuing education and jointly provides CE through PACE for nursing and physician credit, generating revenue from CE activity registration.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels8 records

Core offering

NCODA is a nonprofit medical association that provides oncology healthcare professionals with clinical resources, continuing education, and an international member community. Its core offerings include the Positive Quality Interventions (PQI) clinical library, NCODA CONNECT member portal, patient education tools, accreditation programs for medically integrated pharmacies, and four major annual international conferences serving 16,000+ members across 70+ countries.

Product overview

NCODA (National Community Oncology Dispensing Association) is a medically integrated oncology nonprofit organization that provides a comprehensive suite of professional resources, educational programs, clinical tools, and member services for oncology healthcare professionals. The organization operates primarily through its NCODA CONNECT member portal, supported by an extensive Resource Library, clinical intervention tools (PQIs), patient education materials (Patient Education Sheets, Treatment Calendars, Treatment Support Kits), and clinical reference resources including the Immunotherapy Hub and Clinical White Papers. Key programs include the Oncology Optimized Limited Distribution (OOLD) model, Cost Avoidance Waste Tracker (CAWT), Medically Integrated Pharmacy Accreditation, and the NOHMA research repository. NCODA delivers professional development through accredited Continuing Education activities, annual events (International Spring Forum, International Fall Summit, Global Oncology & Haematology Congress, Oncology Institute), the PQI Podcast, Fellowships, MIOP Residency Program, and Professional Student Organization chapters. The organization also supports patient care through Financial Assistance Search, Oncology Legislation Tracker, and partnerships such as NMDP for blood stem cell donor recruitment.

Differentiator

Problem solved

Functional benefit

Brands

• Positive Quality Interventions (PQI): Clinical intervention resources designed to improve patient outcomes in oncology care.
• Oncology Optimized Limited Distribution (OOLD)
• NOHMA
• NCODA CONNECT

Products and services

• NCODA CONNECT Primary member portal platform providing access to community resources, webinars library, meetings library, community gathering resources, and member resources for oncology healthcare professionals who join NCODA.
• Positive Quality Interventions (PQI) Clinical intervention resources developed by NCODA members to support quality improvements in oncology pharmacy practice, including PQI in Action articles demonstrating practical application. For oncology pharmacists, pharmacy technicians, and care teams.
• Medically Integrated Pharmacy Accreditation (NCODA Center of Excellence) Accreditation program recognizing medically integrated pharmacies that demonstrate excellence in oncology pharmacy integration and patient care standards. For community, health system, and academic oncology practices.
• Oncology Optimized Limited Distribution (OOLD) NCODA-preferred distribution model designed to optimize patient access to oral oncology medications through medically integrated pharmacies, improving care coordination and treatment delivery. For oncology practices and pharmaceutical manufacturers.
• Cost Avoidance Waste Tracker (CAWT) Tool for tracking and reducing waste in oncology pharmacy operations, helping practices identify cost-saving opportunities and improve operational efficiency. For medically integrated oncology pharmacies.
• Continuing Education (CE) Activities ACPE-accredited continuing education programs for pharmacists and pharmacy technicians, with joint provision through PACE for nursing and physician credit. Includes live events and on-demand activities covering clinical and operational topics in oncology.
• NCODA International Spring Forum Annual international meeting bringing together oncology providers and industry partners to address pressing challenges in oncology care, featuring clinical sessions, networking, and continuing education opportunities. For oncology healthcare professionals and industry partners.
• NCODA International Fall Summit Annual fall summit providing educational sessions on patient-centered care and medically integrated oncology, including exhibit hall and continuing education sessions. For oncology healthcare professionals and industry partners.
• NCODA Global Oncology & Haematology Congress Annual international congress bringing together the global oncology community for education, networking, and knowledge sharing on advances in oncology and hematology care.
• NCODA Oncology Institute Annual specialized institute providing intensive educational programming for oncology professionals, held in Atlanta, GA with focus on clinical excellence and practice advancement.
• Clinical White Papers In-depth research publications and clinical analyses addressing key topics in oncology pharmacy, including studies conducted in partnership with organizations like City of Hope and Takeda on oral oncology therapies. For oncology professionals and industry partners.
• Financial Assistance Resource Search Searchable database helping oncology patients and practices find financial assistance programs and resources to support medication affordability and reduce financial toxicity.
• Immunotherapy Hub Centralized resource providing information on immunotherapy treatments including bispecific T-cell engagers (BiTEs), antibody-drug conjugates (ADCs), and emerging immunotherapy approaches in oncology. For oncology pharmacists and care teams.
• NCODA Fellowships Postgraduate fellowship programs supporting professional development in oncology pharmacy, with partnerships across oncology practice, nonprofit leadership, and pharmaceutical industry settings. For early-career pharmacists.
• MIOP Residency Program Medically Integrated Oncology Pharmacy (MIOP) residency program providing advanced training for pharmacists seeking specialized experience in oncology pharmacy practice.
• Oral Anticancer Medication Care Compass Joint resource from NCODA and Oncology Nursing Society (ONS) supporting nursing-specific monitoring strategies and workflows for oral anticancer medications. For oncology nurses.
• Oncology Legislation Tracker Tool for tracking oncology-related legislation and policy developments, helping NCODA members stay informed about regulatory changes affecting cancer care and pharmacy practice.

Quantifiable outcome

• Over 6,000 medically integrated practices supported since 2015
• +3 more outcomes

Named customers2 records

Segments8 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature7 records

Partnerships

Eight partnerships are on record, tiered significant, major and core.

• Consensus Statement Partners (18 cancer community organizations)significantStrategic or Co-development Partner · 1 May 2026NCODA joined with 18 leading cancer organizations including ASH, ASPHO, AACI, ACCC, HOPA, NCCN, ONS, and others to issue a consensus statement on U.S. drug shortages, urging policy action to address supply chain vulnerabilities and promote reliable drug supply.
• City of HopemajorStrategic or Co-development Partner · 1 April 2026NCODA partnered with City of Hope and Takeda on a white paper examining how multidisciplinary care teams support patient access, affordability, and continuity of care for oral oncology therapies in metastatic colorectal cancer. This collaboration represents a significant initiative in advancing medically integrated oncology care.
• TakedamajorStrategic or Co-development Partner · 1 April 2026Takeda collaborated with NCODA and City of Hope on a white paper examining oral oncology therapies in metastatic colorectal cancer. Takeda also supported NCODA's poster presentations at the 2025 Fall Summit focusing on darolutamide clinical data.
• Accreditation Council for Pharmacy Education (ACPE)coreOthers · 1 January 2025NCODA is accredited by ACPE as a provider of continuing pharmacy education for pharmacists and pharmacy technicians, enabling the organization to offer accredited CE programs at its events.
• Partners for Advancing Clinical Education (PACE)coreOthers · 1 January 2025PACE jointly provides continuing education with NCODA for nursing and physician credit at organization events, expanding CE offerings beyond pharmacy to the broader oncology care team.
• American Society of Clinical Oncology (ASCO)majorStrategic or Co-development Partner · 1 January 2025NCODA and ASCO jointly developed MID (Medically Integrated Dispensing) Pharmacy Standards for patient-centered care in medically integrated dispensing practices, establishing quality standards for oncology pharmacy services.
• Oncology Nursing Society (ONS)significantStrategic or Co-development Partner · 1 January 2025NCODA and ONS jointly developed the Oral Anticancer Medication Care Compass, a resource supporting nursing-specific therapeutic strategies and workflows for monitoring oral oncolytics.
• NMDP (formerly Be The Match / National Marrow Donor Program)significantStrategic or Co-development Partner · 1 January 2017NCODA partners with NMDP to support blood stem cell transplant patients. Since 2017, NCODA members have recruited 1,905 new members to the NMDP Registry as potential blood stem cell donors and raised over $48,000 to help patients access and move through blood stem cell transplant. NCODA hosts member-organized fundraising and registry recruitment drives.

Scale indicators12 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• National Comprehensive Cancer Network (NCCN): NCCN is a not-for-profit alliance of leading cancer centers producing oncology practice guidelines. NCCN was also a co-signer on the 2026 drug shortage consensus and operates at a broader oncology system level than NCODA.
• American Pharmacists Association (APhA): APhA is the largest U.S. pharmacy professional society serving all pharmacists. Comparable as a CE provider and advocate for the pharmacy profession, though broader than NCODA's oncology specialization.
• American Society of Clinical Oncology (ASCO): ASCO is the dominant U.S. clinical oncology professional society. NCODA partnered with ASCO on MID Pharmacy Standards, positioning ASCO as a broader incumbent that sets the standards NCODA helps operationalize.
• American Society of Hematology (ASH): ASH is the largest professional society for hematology professionals. ASH co-signed the 2026 drug shortage consensus and overlaps with NCODA on hematology-related pharmacist education and policy.

Emerging players

• American Association for Cancer Education (AACE): AACE focuses on cancer education across the multidisciplinary team. Smaller and more academic than NCODA, with overlapping CE and interdisciplinary training goals in oncology education.

Direct peers

• Association of Community Cancer Centers (ACCC): ACCC serves multidisciplinary oncology care teams across community cancer programs and was a co-signer on NCODA's 2026 drug shortage consensus statement. Comparable as an education, advocacy, and resource-providing oncology membership organization.
• Hematology/Oncology Pharmacy Association (HOPA): HOPA is the largest U.S. hematology/oncology pharmacy association. Directly comparable to NCODA — both serve oncology pharmacists with CE, advocacy, and clinical resources — but HOPA is broader across hematology while NCODA focuses on medically integrated dispensing.
• Oncology Nursing Society (ONS): ONS is the leading oncology nursing association. NCODA co-developed the Oral Anticancer Medication Care Compass with ONS, making them a closely aligned peer in CE delivery and oncology care team resources.
• Community Oncology Alliance (COA): COA advocates for independent community oncology practices and shares NCODA's community-oncology focus and pharmacist/physician engagement. Highly comparable in mission, member profile, and policy-advocacy posture.

Regional players

• European Society for Medical Oncology (ESMO): ESMO is the leading European oncology professional organization. Comparable to NCODA in providing oncology CE, congresses, and clinical resources, but anchored in Europe — relevant given NCODA's 70+ country footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/ncodaorg
• Facebookfacebook.com/NCODAorg
• LinkedInlinkedin.com/company/ncoda
• Instagraminstagram.com/ncodaorg

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NCODA